IO Biotech Investor Relations Material
Latest events
Corporate Presentation
20 Jun, 2025
Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IO Biotech Inc
Access all reports
IO Biotech Inc. is a biotechnology company focused on developing immunotherapies for cancer. The company specializes in therapeutic cancer vaccines designed to stimulate the immune system to target and eliminate tumor cells. Its pipeline includes investigational treatments for various cancers, advancing through clinical trials and regulatory evaluations. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the NASDAQ.
Key slides for IO Biotech Inc
Corporate Presentation
IO Biotech Inc
Corporate Presentation
IO Biotech Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
IOBT
Country
🇺🇸 United States